TIFFANI ARRIAZOLA: Open Payments
NPI 1215434642 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$139 in 6 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $139
Food & beverage: $139
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $81 |
| Genentech USA, Inc. | 1 | $23 |
| Alexion Pharmaceuticals, Inc. | 1 | $18 |
| Caris MPI, Inc. | 1 | $17 |
Products named: LIVTENCITY, Tecentriq, ULTOMIRIS, MI CANCER SEEK.
Industry payments across TX — which companies pay providers there.
